Discovery of calnexin protein鈥檚 role in the blood-brain barrier could lead to new MS treatments.
A discovery led by scientists at the University of Alberta and 9I制作厂免费 is providing hope of a new therapeutic target in Multiple Sclerosis (MS) patients, which could one day be used to prevent the symptoms and progression of the disease.
